Abstract
Blastocystis is a single-celled intestinal parasite commonly found in humans and a broad range of animals all over the world. In humans, its role in health and disease remains unsettled. The aim of our study was to investigate the distribution of Blastocystis and Blastocystis subtypes (ST) in patients with inflammatory bowel disease (IBD) and control subjects. A total of 71 stool samples were collected from IBD patients, 69 and 2 of whom had ulcerative colitis (UC) and Crohn’s Disease (CD), respectively. Moreover, 166 stool samples from healthy subjects were included as control samples. All stool samples were cultivated, and 550-bp fragments of the small subunit ribosomal RNA gene was amplified from Blastocystis-positive cultures. All PCR-positive samples were sequenced. Blastocystis was observed in 9 (12.67%) and 35 (21.1%) IBD patients and healthy controls, respectively. There was no statistically significant correlation between IBD and presence of Blastocystis (P = 0.147). There was a statistically significant correlation between age and Blastocystis colonization in the IBD group (P < 0.05), but not among healthy controls. No significant correlation between gender and colonization was observed. ST1 and ST3 were obtained from 1 (12.5%) and 7 (87.5%) IBD patients, respectively, while in the healthy control group, subtypes 1, 2, and 3 were found in 14 (40%), 12 (34.28%), and 9 (25.72%), respectively. Phylogenetic analysis showed no variation in the distribution of subtypes nor intra-subtype genetic diversity between samples acquired from IBD patients and healthy controls. This study showed a trend towards a lower prevalence of Blastocystis in IBD patients than in control subjects. ST3 sequences isolated from IBD patients and control individuals did not appear to differ genetically.
Similar content being viewed by others
References
Clark CG, van der Giezen M, Alfellani MA, Stensvold CR (2013) Recent developments in Blastocystis research. Adv Parasitol 82:1–32. doi:10.1016/B978-0-12-407706-5.00001-0
Stensvold CR, Clark CG (2016) Current status of Blastocystis: a personal view. Parasitol Int 65(6 Pt B):763–771. doi:10.1016/j.parint.2016.05.015
Duda A, Kosik-Bogacka D, Lanocha N, Szymanski S (2014) Blastocystis hominis—parasites or commensals? Ann Acad Med Stetin 60(1):23–28
Tan KS (2008) New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 21(4):639–665. doi:10.1128/CMR.00022-08
Elghareeb AS, Younis MS, El Fakahany AF, Nagaty IM, Nagib MM (2015) Laboratory diagnosis of Blastocystis spp. in diarrheic patients. Trop Parasitol 5(1):36–41. doi:10.4103/2229-5070.149919
El Safadi D et al (2014) Children of Senegal River basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 14:164. doi:10.1186/1471-2334-14-164
Scanlan PD, Knight R, Song SJ, Ackermann G, Cotter PD (2016) Prevalence and genetic diversity of Blastocystis in family units living in the United States. Infect Gen Evol 45:95–97. doi:10.1016/j.meegid.2016.08.018
Poulsen CS, Efunshile AM, Nelson JA, Stensvold CR (2016) Epidemiological aspects of Blastocystis colonization in children in Ilero, Nigeria. Am J Trop Med Hyg 95(1):175–179. doi:10.4269/ajtmh.16-0074
Lee LI, Chye TT, Karmacharya BM, Govind SK (2012) Blastocystis sp.: waterborne zoonotic organism, a possibility? Parasite Vectors 5:130. doi:10.1186/1756-3305-5-130
Tan KS, Mirza H, Teo JD, Wu B, Macary PA (2010) Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep 12(1):28–35. doi:10.1007/s11908-009-0073-8
Balint A, Doczi I, Bereczki L et al (2014) Do not forget the stool examination!-cutaneous and gastrointestinal manifestations of Blastocystis sp. infection. Parasitol Res 113(4):1585–1590. doi:10.1007/s00436-014-3805-0
Fleta Zaragozano J, Clavel Parrilla A, Castillo Garcia FJ, Bueno Lozano M, Sarria Chueca A (1993) Blastocystis hominis and abdominal pain in childhood. An Esp Pediatr 38(1):13–16
Gupta R, Parsi K (2006) Chronic urticaria due to Blastocystis hominis. Aust J Dermatol 47(2):117–119. doi:10.1111/j.1440-0960.2006.00244.x
Hameed DM, Hassanin OM, Zuel-Fakkar NM (2011) Association of Blastocystis hominis genetic subtypes with urticaria. Parasitol Res 108(3):553–560. doi:10.1007/s00436-010-2097-2
Kick G, Rueff F, Przybilla B (2002) Palmoplantar pruritus subsiding after Blastocystis hominis eradication. Acta Dermatol Venereol 82(1):60
El Deeb HK, Salah-Eldin H, Khodeer S (2012) Blastocystis hominis as a contributing risk factor for development of iron deficiency anemia in pregnant women. Parasitol Res 110(6):2167–2174. doi:10.1007/s00436-011-2743-3
Yavasoglu I, Kadikoylu G, Uysal H, Ertug S, Bolaman Z (2008) Is Blastocystis hominis a new etiologic factor or a coincidence in iron deficiency anemia? Eur J Haematol 81(1):47–50. doi:10.1111/j.1600-0609.2008.01080.x
Micheloud D, Jensen J, Fernandez-Cruz E, Carbone J (2007) Chronic angioedema and blastocystis hominis infection. Revist Gastroenterol del Peru [Article in Spanish] 27(2):191–193
Alfellani MA, Taner-Mulla D, Jacob AS et al (2013) Genetic diversity of Blastocystis in livestock and zoo animals. Protist 164(4):497–509. doi:10.1016/j.protis.2013.05.003
Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Onuoha ES, Fagbenro-Beyioku AF, Clark CG (2013) Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop 126(1):11–18. doi:10.1016/j.actatropica.2012.12.011
Ko JK, Auyeung KK (2014) Inflammatory bowel disease: etiology, pathogenesis and current therapy. Curr Pharm Des 20(7):1082–1096
Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3–S9
Corridoni D, Arseneau KO, Cominelli F (2014) Inflammatory bowel disease. Immunol Lett 161(2):231–235. doi:10.1016/j.imlet.2014.04.004
Goyal N, Rana A, Ahlawat A, Bijjem KR, Kumar P (2014) Animal models of inflammatory bowel disease: a review. Inflammopharmacol 22(4):219–233. doi:10.1007/s10787-014-0207-y
Boirivant M, Cossu A (2012) Inflammatory bowel disease. Oral Dis 18(1):1–15. doi:10.1111/j.1601-0825.2011.01811.x
Sartor RB, Mazmanian SK (2012) Intestinal microbes in inflammatory bowel diseases. Am J Gastroenterol Suppl 1(1):15–21
Becker C, Neurath MF, Wirtz S (2015) The intestinal microbiota in inflammatory bowel disease. ILAR J 56(2):192–204. doi:10.1093/ilar/ilv030
Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I (2014) Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol 20(5):1192–1210. doi:10.3748/wjg.v20.i5.1192
Marchesi JR, Adams DH, Fava F et al (2016) The gut microbiota and host health: a new clinical frontier. Gut 65(2):330–339. doi:10.1136/gutjnl-2015-309990
Ragavan ND, Kumar S, Chye TT, Mahadeva S, Shiaw-Hooi H (2015) Blastocystis sp. in irritable bowel syndrome (IBS) — detection in stool aspirates during colonoscopy. PLoS One 10(9):e0121173. doi:10.1371/journal.pone.0121173
Mumcuoglu I, Coskun FA, Aksu N, Purnak T, Gungor C (2013) Role of Dientamoeba fragilis and Blastocystis spp. in irritable bowel syndrome. Turkiye Parazitol Derg (Turkish Society for Parasitology) 37(2):73–77. doi:10.5152/tpd.2013.19
Surangsrirat S, Thamrongwittawatpong L, Piyaniran W et al (2010) Assessment of the association between Blastocystis infection and irritable bowel syndrome. J Med Assoc Thai 93(Suppl 6):S119–S124
Dogruman-Al F, Simsek Z, Boorom K et al (2010) Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD patients in Ankara, Turkey. PLoS One 5(11):e15484. doi:10.1371/journal.pone.0015484
Dogruman-Al F, Kustimur S, Yoshikawa H et al (2009) Blastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, Turkey. Mem Inst Oswaldo Cruz 104(5):724–727
Petersen AM, Stensvold CR, Mirsepasi H et al (2013) Active ulcerative colitis associated with low prevalence of Blastocystis and Dientamoeba fragilis infection. Scand J Gastroenterol 48(5):638–639. doi:10.3109/00365521.2013.780094
Jalallou N, Iravani S, Rezaeian M, Alinaghizade A, Mirjalali H (2017) Subtypes distribution and frequency of Blastocystis sp., isolated from diarrheic and non-diarrheic patients. Iran J Parasitol 12(1):63–68
Alinaghizade A, Mirjalali H, Mohebali M, Stensvold CR, Rezaeian M (2017) Inter- and intra-subtype variation of Blastocystis subtypes isolated from diarrheic and non-diarrheic patients in Iran. Infect Gen Evol 50:77–82. doi:10.1016/j.meegid.2017.02.016
Lanuza MD, Carbajal JA, Villar J, Borras R (1997) Description of an improved method for Blastocystis hominis culture and axenization. Parasitol Res 83(1):60–63
Bohm-Gloning B, Knobloch J, Walderich B (1997) Five subgroups of Blastocystis hominis from symptomatic and asymptomatic patients revealed by restriction site analysis of PCR-amplified 16S-like rDNA. Trop Med Int Health 2(8):771–778
Stensvold CR, Arendrup MC, Jespersgaard C, Molbak K, Nielsen HV (2007) Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diag Microbiol Infect Dis 59(3):303–307. doi:10.1016/j.diagmicrobio.2007.06.003
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30(12):2725–2729. doi:10.1093/molbev/mst197
Basak S, Rajurkar MN, Mallick SK (2014) Detection of Blastocystis hominis: a controversial human pathogen. Parasitol Res 113(1):261–265. doi:10.1007/s00436-013-3652-4
Engsbro AL, Stensvold CR (2012) Blastocystis: to treat or not to treat...But how? Clin Infect Dis : Off Publ Infect Dis Soc Am 55(10):1431–1432. doi:10.1093/cid/cis699
Scanlan PD (2012) Blastocystis: past pitfalls and future perspectives. Trend Parasitol 28(8):327–334. doi:10.1016/j.pt.2012.05.001
Scanlan PD, Stensvold CR (2013) Blastocystis: getting to grips with our guileful guest. Trend Parasitol 29(11):523–529. doi:10.1016/j.pt.2013.08.006
Andersen LO, Stensvold CR (2016) Blastocystis in health and disease: are we moving from a clinical to a public health perspective? J Clin Microbiol 54(3):524–528. doi:10.1128/JCM.02520-15
Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J et al (2012) Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 110(3):1269–1275. doi:10.1007/s00436-011-2626-7
Nagel R, Traub RJ, Kwan MM, Bielefeldt-Ohmann H (2015) Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls. Parasite Vector 8(1):453. doi:10.1186/s13071-015-1069-x
Yamamoto-Furusho JK, Torijano-Carrera E (2010) Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease course. Digestion 82(1):18–23. doi:10.1159/000273871
Cekin AH, Cekin Y, Adakan Y, Tasdemir E, Koclar FG, Yolcular BO (2012) Blastocystosis in patients with gastrointestinal symptoms: a case–control study. BMC Gastroenterol 12(1):122. doi:10.1186/1471-230x-12-122
Rossen NG et al (2015) Low prevalence of Blastocystis sp. in active ulcerative colitis patients. Eur J Clin Microbiol Infect Dis 34(5):1039–1044. doi:10.1007/s10096-015-2312-2
Moosavi A, Haghighi A, Mojarad EN et al (2012) Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran. Parasitol Res 111(6):2311–2315. doi:10.1007/s00436-012-3085-5
Badparva E, Sadraee J, Kheirandish F (2015) Genetic diversity of Blastocystis isolated from cattle in Khorramabad, Iran. Jundishapur J Microbiol 8(3):e14810. doi:10.5812/jjm.14810
Badparva E, Sadraee J, Kheirandish F, Frouzandeh M (2014) Genetic diversity of human Blastocystis isolates in khorramabad, central iran. Iran J Parasitol 9(1):44–49
Motazedian H, Ghasemi H, Sadjjadi SM (2008) Genomic diversity of Blastocystis hominis from patients in southern Iran. Ann Trop Med Parasitol 102(1):85–88. doi:10.1179/136485908X252197
Abu-Madi M, Aly M, Behnke JM, Clark CG, Balkhy H (2015) The distribution of Blastocystis subtypes in isolates from Qatar. Parasite Vector 8:465. doi:10.1186/s13071-015-1071-3
Souppart L et al (2010) Subtype analysis of Blastocystis isolates from symptomatic patients in Egypt. Parasitol Res 106(2):505–511. doi:10.1007/s00436-009-1693-5
Pandey PK et al (2015) Prevalence and subtype analysis of Blastocystis in healthy Indian individuals. Infect Gen Evol 31:296–299. doi:10.1016/j.meegid.2015.02.012
AbuOdeh R, Ezzedine S, Samie A, Stensvold CR, ElBakri A (2016) Prevalence and subtype distribution of Blastocystis in healthy individuals in Sharjah, United Arab Emirates. Infect Gen Evol 37:158–162. doi:10.1016/j.meegid.2015.11.021
Das R, Khalil S, Mirdha BR, Makharia GK, Dattagupta S, Chaudhry R (2016) Molecular characterization and subtyping of Blastocystis species in irritable bowel syndrome patients from North India. PLoS One 11(1):e0147055. doi:10.1371/journal.pone.0147055
Coskun A, Malatyali E, Ertabaklar H, Yasar MB, Karaoglu AO, Ertug S (2016) Blastocystis in ulcerative colitis patients: genetic diversity and analysis of laboratory findings. Asia Pac J Trop Med 9(9):916–919. doi:10.1016/j.apjtm.2016.07.018
Mattiucci S, Crisafi B, Gabrielli S, Paoletti M, Cancrini G (2015) Molecular epidemiology and genetic diversity of Blastocystis infection in humans in Italy. Epidemiol Infect 1-12. doi:10.1017/S0950268815001697
Mirza H, Tan KS (2009) Blastocystis exhibits inter- and intra-subtype variation in cysteine protease activity. Parasitol Res 104(2):355–361. doi:10.1007/s00436-008-1203-1
Wu Z, Mirza H, Tan KS (2014) Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7. PLoS Neglected Trop Dis 8(5):e2885. doi:10.1371/journal.pntd.0002885
Sio SW, Puthia MK, Lee AS, Lu J, Tan KS (2006) Protease activity of Blastocystis hominis. Parasitol Res 99(2):126–130. doi:10.1007/s00436-006-0131-1
Puthia MK, Sio SW, Lu J, Tan KS (2006) Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect Immun 74(7):4114–4123. doi:10.1128/IAI.00328-06
Puthia MK, Vaithilingam A, Lu J, Tan KS (2005) Degradation of human secretory immunoglobulin a by Blastocystis. Parasitol Res 97(5):386–389. doi:10.1007/s00436-005-1461-0
Poirier P, Wawrzyniak I, Vivares CP, Delbac F, El Alaoui H (2012) New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Path 8(3):e1002545. doi:10.1371/journal.ppat.1002545
Boorom KF et al (2008) Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasite Vector 1(1):40. doi:10.1186/1756-3305-1-40
Abdel-Hameed DM, Hassanin OM (2011) Proteaese activity of Blastocystis hominis subtype3 in symptomatic and asymptomatic patients. Parasitol Res 109(2):321–327. doi:10.1007/s00436-011-2259-x
Audebert C, Even G, Cian A et al (2016) Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota. Sci Rep 6:25255. doi:10.1038/srep25255
Nourrisson C, Scanzi J, Pereira B et al (2014) Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One 9(11):e111868. doi:10.1371/journal.pone.0111868
Scanlan PD, Stensvold CR, Rajilic-Stojanovic M et al (2014) The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol 90(1):326–330. doi:10.1111/1574-6941.12396
Andersen LO, Bonde I, Nielsen HB, Stensvold CR (2015) A retrospective metagenomics approach to studying Blastocystis. FEMS Microbiol Ecol 91(7). doi:10.1093/femsec/fiv072
Rook GA (2010) 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Darwinian medicine and the ‘hygiene’ or‘old friends’ hypothesis. Clin Exp Immunol 160(1):70–79
Rook GA (2011) Hygiene and other early childhood influences on the subsequent function of the immune system. Dig Dis (Basel, Switzerland) 29(2):144–153. doi:10.1159/000323877
Acknowledgements
The authors would like to thank all of the colleagues of the Foodborne and Waterborne Diseases Research Center and Gastroenterology and Liver diseases Research Institute for their laboratory cooperation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This project was financially supported by the Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran with grant number: RIGLD 832.
Ethical approval
The present study was approved by the Ethics Committee of Shahid Beheshti University of Medical Sciences.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mirjalali, H., Abbasi, M.R., Naderi, N. et al. Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran. Eur J Clin Microbiol Infect Dis 36, 2335–2342 (2017). https://doi.org/10.1007/s10096-017-3065-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-017-3065-x